Antibodies News and Research

RSS

Cocktail of IgG3 antibodies could have a potent clinical effect against SARS-CoV-2

Is it possible to improve the antibodies that the body produces to fight SARS-CoV2? In a study led by researchers from Lund University in Sweden, this was investigated by redesigning antibodies and combining them against the virus.

18 Apr 2023

New biologic inactivates potent opioid and reverses overdose

A new therapeutic designed by Scripps Research chemists can alter the molecular structure of the potent opioid carfentanil, inactivating the opioid and reversing a carfentanil overdose.

18 Apr 2023

Beckman Coulter Life Sciences achieves industry-first reagent certification to help prepare labs for IVDR and to clear confusion

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, is leading the way to help laboratories prepare for critical upgrades to comply with the new In Vitro Diagnostic Medical Devices Regulation (IVDR), and to clear up confusion for laboratories that will soon be governed by IVDR.

From Beckman Coulter Life Sciences 18 Apr 2023

Is there an association between COVID-19 and the risk of developing an autoimmune disease?

Researchers reviewed data on the incidence of autoimmune diseases in the post-acute coronavirus disease 2019 period.

17 Apr 2023

Pregnant women show unique immune response to COVID-19

Researchers compare the adaptive, innate, and humoral immune responses between pregnant and non-pregnant women with COVID-19.

16 Apr 2023

How SARS-CoV-2 Omicron subvariants have evolved to evade host T-cell immunity

Researchers investigate whether SARS-CoV-2 and its variants have evolved to evade CD8+ T cell-mediated immunity.

15 Apr 2023

Antibody response to SARS-CoV-2 is stronger and more durable in infants and young children

Researchers evaluated humoral responses to severe acute respiratory syndrome coronavirus 2 in infants.

15 Apr 2023

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Researchers developed a novel intranasal vaccine candidate for coronavirus disease 2019 (COVID-19).

14 Apr 2023

Study finds no association between maternal SARS-CoV-2 infection and infant neurodevelopment

Researchers assessed whether exposure to SARS-CoV-2 infections during pregnancy impacted infant neurodevelopment.

13 Apr 2023

B cells use mechanical force to pull antigen molecules off other cells

Most cells evolve slowly, accumulating incremental changes that better suit their environments. Immune cells, because they must adapt rapidly to counter new threats, evolve much more quickly.

13 Apr 2023

AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice

The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time.

13 Apr 2023

Using an implantable nanofluidic device to tame pancreatic cancer

Houston Methodist nanomedicine researchers have found a way to tame pancreatic cancer - one of the most aggressive and difficult to treat cancers - by delivering immunotherapy directly into the tumor with a device that is smaller than a grain of rice.

13 Apr 2023

MHRA research evaluates two different approaches to cancer therapies

The report 'Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue', published in the PLOS ONE journal, highlights MHRA research which showed that genetic engineering of antibodies used to activate and support the immune system against cancer leads to improvements in their reliability and effectiveness.

13 Apr 2023

Antibodies News and Research

Cocktail of IgG3 antibodies could have a potent clinical effect against SARS-CoV-2

New biologic inactivates potent opioid and reverses overdose

Beckman Coulter Life Sciences achieves industry-first reagent certification to help prepare labs for IVDR and to clear confusion

Is there an association between COVID-19 and the risk of developing an autoimmune disease?

Pregnant women show unique immune response to COVID-19

How SARS-CoV-2 Omicron subvariants have evolved to evade host T-cell immunity

Antibody response to SARS-CoV-2 is stronger and more durable in infants and young children

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Study finds no association between maternal SARS-CoV-2 infection and infant neurodevelopment

B cells use mechanical force to pull antigen molecules off other cells

AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice

Using an implantable nanofluidic device to tame pancreatic cancer

MHRA research evaluates two different approaches to cancer therapies

New tool provides insight into the developmental history of certain immune cells

Award-winning project uses INTEGRA pipettes for success in international genetic engineering competition

The virological characteristics of XBB.1.16

The identification of vaccinee-derived antibodies with broad-spectrum Omicron neutralization activity

New organoid platform could make vaccine screening quicker and greatly reduce animal testing

SARS-CoV-2 infection among infants born to maternal COVID-19 cases during Omicron variant predominance

New insights into how Omicron variants avoid destruction by "killer" T cells

A new way of characterising biomolecules eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest Life Science News